Resonance Health News June 2015

Welcome to our June 2015 newsletter. In this issue we have some latest news from the clinical community, details of exciting developments in our R&D department and some new Resonance Health faces to introduce.

To read the full newsletter please click here


LIC-NET Italy Advances Best Practice in Iron Monitoring

Headed by Professor Aurelio Maggio (Director of the Department of Haematology and Oncology at Villa Sofia-Cervello Hospital, Palermo, Italy) the Liver Iron Cutino Network (LIC-NET) is a growing network of 12 Italian hospitals working to improve the management of iron overload in patients through accurate assessment of liver iron concentration.

Read more

FerriScan Funding Signals End to Liver Biopsy for Scottish Haemoglobinopathy Patients

The Scottish Paediatric and Adult Haemoglobinopathies Network has secured central funding from the Scottish National Services Directorate for adult patients to access FerriScan R2-MRI (the gold standard measurement of Liver Iron Concentration).

Read more

Resonance Health Partners with CSIRO

We are delighted to announce a new collaboration with one of Australia’s leading research organisations; the Commonwealth Scientific and Industrial Research Organisation (CSIRO), to apply their expertise in our product development pipeline.

Read more

Advances for Resonance Health in Measurement of Liver Fibrosis

Excitement is building at Resonance Health regarding promising results from a prototype liver fibrosis measurement. The prototype has been demonstrated to distinguish between low and high fibrosis scores in a patient cohort with Hepatitis C.

Read more

US study addressing fatty liver disease in children using HepaFat-Scan® technology

We are pleased to announce a collaboration with a prestigious children’s hospital in the USA (Children’s Healthcare of Atlanta) who will perform a validation study of HepaFat-Scan® - our non-invasive medical imaging solution that utilises MRI to accurately measure liver fat.

Read more